Stay updated with breaking news from Resources Report. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The UK oil and gas licensing round announced October 6 by the North Sea Transition Authority, will boost British gas supplies, sustain the UK’s energy industry and strengthen plans for a low-carbon future, said Offshore Energies UK (OEUK).
– Cabozantinib in combination with nivolumab and ipilimumab significantly reduced the risk of disease progression or death compared with the combination of nivolumab and ipilimumab –– Median progression-free survival was not yet reached with the combination of cabozantinib, nivolumab and ipilimumab versus 11.3 month...
08.09.2022 - Exelixis, Inc. (Nasdaq: EXEL) today announced detailed results from COSMIC-313, an ongoing phase 3 pivotal trial evaluating the combination of cabozantinib (CABOMETYX), nivolumab and ipilimumab versus the combination of nivolumab and ipilimumab in ...
- Cabozantinib in combination with nivolumab and ipilimumab significantly reduced the risk of disease progression or death compared with the combination of nivolumab and ipilimumab - - Median progression-free
/CNW/ - Pan Orient Energy Corp. ("Pan Orient" or the "Company") (TSXV: POE) reports 2022 second quarter consolidated financial and operating results. Please...